MEDSYS
ActiveSummary
MEDSYS has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €239,662 and a net result of €87,987. Equity is shrinking by ~7% per year across the filed fiscal years. Its solvency ranks better than 66% of 656 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 29 days after the deadline; the sector median for financial year 2024 is 2 days before the deadline, and 40% of the sector filed late.
Checked, nothing found (2)
History
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Click a name to add, emphasise or remove a line.
Peer companies
Historical observationOf the 31,324 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,324 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €157,110 | €145,551 | €182,046 | €142,052 | €81,843 | ▼ 42.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €668 | €649 | €514 | €379 | - | - |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | -€92,192 | - | - | - | - |
| Other operating charges640/8 | €13,925 | €143 | €1,917 | €45 | €565 | ▲ 1,155% |
| Gross operating margin9900 | €214,847 | €179,270 | €130,565 | €183,064 | €170,272 | ▼ 7.0% |
| Operating profit (loss)9901 | €43,144 | €125,118 | -€53,912 | €40,588 | €87,864 | ▲ 116% |
| Financial income75/76B | €3,012 | €140 | €0 | €4,049 | €1,039 | ▼ 74.3% |
| Recurring financial income75 | €2,924 | €140 | €0 | €90 | €1,039 | ▲ 1,060% |
| Non-recurring financial income76B | €88 | - | - | €3,959 | - | - |
| Financial charges65/66B | €20,360 | €172,012 | €16,844 | €1,861 | €644 | ▼ 65.4% |
| Recurring financial charges65 | €6,360 | €172,012 | €16,103 | €1,797 | €644 | ▼ 64.2% |
| Non-recurring financial charges66B | €14,000 | - | €741 | €64 | - | - |
| Profit (loss) for the period before taxes9903 | €25,796 | -€46,754 | -€70,756 | €42,776 | €88,259 | ▲ 106% |
| Income taxes67/77 | €1,999 | €1,999 | -€1,862 | €241 | €272 | ▲ 12.6% |
| Profit (loss) for the period9904 | €23,798 | -€48,752 | -€68,894 | €42,535 | €87,987 | ▲ 107% |
| Profit (loss) for the period to be appropriated9905 | €23,798 | -€48,752 | -€68,894 | €42,535 | €87,987 | ▲ 107% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €469,513 | €398,821 | €261,076 | €330,221 | €403,669 | ▲ 22.2% |
| Fixed assets21/28 | - | €893 | €379 | - | - | - |
| Tangible fixed assets22/27 | €0 | €893 | €379 | - | - | - |
| Furniture and vehicles24 | - | €893 | €379 | - | - | - |
| Financial fixed assets28 | €0 | - | - | - | - | - |
| Current assets29/58 | €469,513 | €397,928 | €260,697 | €330,221 | €403,669 | ▲ 22.2% |
| Stocks and contracts in progress3 | €152,502 | €75,856 | €102,337 | €110,786 | €109,547 | ▼ 1.1% |
| Stocks30/36 | €152,502 | €75,856 | €102,337 | €110,786 | €109,547 | ▼ 1.1% |
| Amounts receivable within one year40/41 | €115,024 | €89,947 | €115,196 | €133,303 | €140,564 | ▲ 5.4% |
| Trade receivables40 | €83,019 | €89,947 | €115,196 | €133,303 | €133,064 | ▼ 0.2% |
| Other amounts receivable41 | €32,005 | - | - | - | €7,500 | - |
| Cash at bank and in hand54/58 | €201,987 | €232,124 | €41,172 | €86,132 | €153,557 | ▲ 78.3% |
| Deferred charges and accrued income490/1 | - | - | €1,992 | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €469,513 | €398,821 | €261,076 | €330,221 | €403,669 | ▲ 22.2% |
| Equity10/15 | €403,328 | €301,525 | €232,631 | €275,166 | €239,662 | ▼ 12.9% |
| Contributions10/11 | €200,000 | €200,000 | €200,000 | €200,000 | €200,000 | = |
| Capital10 | €100,000 | €100,000 | €100,000 | €100,000 | €100,000 | = |
| Issued capital100 | €100,000 | €100,000 | €100,000 | €100,000 | €100,000 | = |
| Outside capital11 | €100,000 | €100,000 | €100,000 | €100,000 | €100,000 | = |
| Share premium1100/10 | €100,000 | €100,000 | €100,000 | €100,000 | €100,000 | = |
| Reserves13 | €203,328 | €119,952 | €119,952 | €119,952 | €39,662 | ▼ 66.9% |
| Non-distributable reserves130/1 | €19,675 | €19,675 | €19,675 | €19,675 | €19,675 | = |
| Legal reserve130 | €19,675 | €19,675 | €19,675 | €19,675 | €19,675 | = |
| Distributable reserves133 | €183,653 | €100,277 | €100,277 | €100,277 | €19,987 | ▼ 80.1% |
| Profit (loss) carried forward14 | - | -€18,428 | -€87,321 | -€44,787 | - | - |
| Amounts payable17/49 | €66,184 | €97,296 | €28,445 | €55,055 | €164,007 | ▲ 198% |
| Amounts payable within one year42/48 | €66,184 | €96,496 | €28,445 | €55,055 | €164,007 | ▲ 198% |
| Trade debts44 | €40,647 | €29,655 | €20,448 | €44,987 | €24,002 | ▼ 46.6% |
| Suppliers440/4 | €40,647 | €29,655 | €20,448 | €44,987 | €24,002 | ▼ 46.6% |
| Taxes, remuneration and social security45 | €25,537 | €16,442 | €7,997 | €10,068 | €16,514 | ▲ 64.0% |
| Taxes450/3 | €9,151 | €14,828 | €1,485 | - | €5,613 | - |
| Remuneration and social security454/9 | €16,386 | €1,613 | €6,512 | €10,068 | €10,901 | ▲ 8.3% |
| Other amounts payable47/48 | - | €50,399 | - | - | €123,491 | - |
| Accrued charges and deferred income492/3 | - | €800 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €23,798 | -€48,752 | -€68,894 | €42,535 | €87,987 | ▲ 107% |
| + Depreciation and write-downs630 | €668 | €649 | €514 | €379 | - | - |
| Operating cash flow (approximation) | €24,465 | -€48,103 | -€68,380 | €42,914 | €87,987 | ▲ 105% |
| Investment in fixed assets (approximation) | - | - | €0 | - | - | - |
| Change in cash | - | €30,137 | -€190,953 | €44,961 | €67,425 | ▲ 50.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
About the unread acts
We know of 11 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue du Gaillard,Sauv. 35030 Gembloux1 establishment unit
Structure & network
Owners and holdings
1 ownerChain of control
- GUALIMA
- MEDSYS
Highest known parent: GUALIMA. The sources do not say who stands above it.
Owners 1
- GUALIMAparent100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
Identification & contact
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.